Prometheus Biosciences Price on June 14, 2023
RXDXDelisted Stock | USD 199.92 0.24 0.12% |
If you're considering investing in Prometheus Stock, it is important to understand the factors that can impact its price. As of today, the current price of Prometheus Biosciences stands at 199.92, as last reported on the 29th of November, with the highest price reaching 199.98 and the lowest price hitting 199.60 during the day. We have found thirty technical indicators for Prometheus Biosciences, which you can use to evaluate the volatility of the company. Please check Prometheus Biosciences' Semi Deviation of 0.764, coefficient of variation of 838.32, and Risk Adjusted Performance of 0.1005 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Prometheus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Prometheus |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
RXDX |
Based on monthly moving average Prometheus Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Prometheus Biosciences by adding Prometheus Biosciences to a well-diversified portfolio.
Related Headline
Terns Pharmaceuticals Headline on 14th of June 2023
Filed transaction by Terns Pharmaceuticals Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Prometheus Biosciences Valuation on June 14, 2023
It is possible to determine the worth of Prometheus Biosciences on a given historical date. On June 14, 2023 Prometheus was worth 199.02 at the beginning of the trading date compared to the closed value of 199.74. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Prometheus Biosciences stock. Still, in general, we apply an absolute valuation method to find Prometheus Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Prometheus Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Prometheus Biosciences' related companies.
Open | High | Low | Close | Volume | |
198.99 | 199.02 | 198.92 | 198.99 | 3,518,039 | |
06/14/2023 | 199.02 | 199.74 | 199.02 | 199.74 | 933,769 |
199.68 | 199.98 | 199.60 | 199.92 | 1,787,233 |
Backtest Prometheus Biosciences | | | Prometheus Biosciences History | | | Prometheus Biosciences Valuation | Previous | Next |
Prometheus Biosciences Trading Date Momentum on June 14, 2023
On June 15 2023 Prometheus Biosciences was traded for 199.92 at the closing time. The top price for the day was 199.98 and the lowest listed price was 199.60 . The trading volume for the day was 1.8 M. The trading history from June 15, 2023 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 0.09% . The trading delta at closing time against the current closing price is 0.03% . |
Prometheus Biosciences Fundamentals Correlations and Trends
By evaluating Prometheus Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Prometheus Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Prometheus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Prometheus Biosciences Stock history
Prometheus Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Prometheus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Prometheus Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Prometheus Biosciences stock prices may prove useful in developing a viable investing in Prometheus Biosciences
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases . Prometheus Biosciences, Inc. was incorporated in 2016 and is headquartered in San Diego, California. Prometheus Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.
Prometheus Biosciences Stock Technical Analysis
Prometheus Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Prometheus Biosciences Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Prometheus Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Prometheus Biosciences November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Prometheus Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Prometheus Biosciences shares will generate the highest return on investment. By undertsting and applying Prometheus Biosciences stock market strength indicators, traders can identify Prometheus Biosciences entry and exit signals to maximize returns
Prometheus Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Prometheus Biosciences' price direction in advance. Along with the technical and fundamental analysis of Prometheus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Prometheus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1005 | |||
Jensen Alpha | 1.04 | |||
Total Risk Alpha | (0.28) | |||
Sortino Ratio | 0.4986 | |||
Treynor Ratio | (11.84) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Prometheus Stock
If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |